Inicio › Cáncer de pulmón › Colorado

Ensayos clínicos de Cáncer de pulmón en Colorado

38 estudios sobre Cáncer de pulmón buscan participantes en Colorado.

Ciudades en Colorado

Texto oficial del estudio (inglés)

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Shaw Cancer Center, Edwards

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Intermountain Health Cancer Center Lutheran Hospital, Golden
Cancer Centers of Colorado St. Mary's Regional Hospital, Grand Junction
Intermountain Health St. Mary's Regional Hospital, Grand Junction
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Kaiser Permanente-Franklin, Denver
Saint Mary's Hospital and Regional Medical Center, Grand Junction
Kaiser Permanente-Rock Creek, Lafayette
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Rocky Mountain Cancer Centers-Aurora, Aurora
UCHealth University of Colorado Hospital, Aurora
Rocky Mountain Cancer Centers-Boulder, Boulder
y 13 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

VA Western Colorado Health Care System, Grand Junction

Reclutando

Edades de 50 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07168993

The Vanguard Study: Testing a New Way to Screen for Cancer

Keefe Memorial Hospital, Cheyenne Wells
Kaiser Permanente-Franklin, Denver
Poudre Valley Hospital, Fort Collins
y 5 más

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Valkyrie Clinical Trials - Colorado, Lakewood

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

UC Health Oncology Research, Colorado Springs
Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System, Fort Collins
Grand Valley Oncology, Grand Junction

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Presbyterian/St Lukes Medical Center, Denver
Sarah Cannon Research Institute at HealthONE, Denver

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07519655

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Rocky Mountain Regional VA Medical Center, Aurora
UCHealth University of Colorado Hospital, Aurora
Penrose-Saint Francis Healthcare, Colorado Springs
y 15 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Rocky Mountain Cancer Centers-Aurora, Aurora
Rocky Mountain Cancer Centers-Boulder, Boulder
Kaiser Permanente-Franklin, Denver
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0182, Aurora

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07492680

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Rocky Mountain Cancer Centers, Lone Tree

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

University of Colorado Cancer Center at UC Health Sciences Center, Aurora

ReclutandoEstudio observacional

Edades de 21 a 90 · Todos los sexos · Actualizado el 3 nov 2026 · NCT00900419

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Vail Health, Vail

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

University of Colorado Health, Aurora

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07185997

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

University of Colorado Hospital, Aurora

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07499674

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Sarah Cannon Research Institute Denver, Denver

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Sarah Cannon Research Institute - Denver DDU, Denver

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06582017

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Denver

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

University of Colorado - Aurora Cancer Center, Aurora

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

UCHealth University of Colorado Hospital, Aurora
UCHealth Memorial Hospital Central, Colorado Springs
Memorial Hospital North, Colorado Springs
y 4 más

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Rocky Mountain Cancer Center, Denver

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Rocky Mountain Cancer Centers, Boulder

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

University of Colorado Cancer Center, Aurora

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

University of Colorado Cancer Center, Aurora

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06343402

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

UCHealth University of Colorado Hospital, Aurora
Rocky Mountain Cancer Centers-Penrose, Colorado Springs
UCHealth Memorial Hospital Central, Colorado Springs
y 8 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Sarah Cannon Research Institute at HealthONE, Denver

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT05652686

Integrated Cancer Repository for Cancer Research

Advent Health, Greenwood Village

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Sarah Cannon, SCRI Oncology Partners - Health One, Denver

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT04678648

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

UCHealth University of Colorado Hospital, Aurora
UCHealth Memorial Hospital Central, Colorado Springs
Memorial Hospital North, Colorado Springs
y 5 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

University of Colorado Cancer Center, Aurora

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 abr 2026 · NCT05987644

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Sarah Cannon Research Institute (SCRI) at HealthONE, Denver

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 mar 2026 · NCT05948865

Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer

University of Colorado Cancer Center, Aurora

ReclutandoEstudio observacional

Edades de 18 a 85 · Todos los sexos · Actualizado el 18 feb 2026 · NCT01580982

Improving Care for Rural Patients With Solid Tumors

University of Colorado Hospital, Aurora
Memorial Hospital Central, Colorado Springs
Memorial Hospital North, Colorado Springs
y 10 más

Reclutando

Edades de 18 a 99 · Todos los sexos · Actualizado el 5 feb 2026 · NCT04916990

Specimen Banking From Patients With Lung Cancer

University of Colorado Cancer Center, Aurora

ReclutandoEstudio observacional

Edades de 18 a 85 · Todos los sexos · Actualizado el 29 ene 2026 · NCT01585675

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 ene 2026 · NCT05179408

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Aurora
Massive Bio SYNERGY-AI site, Denver
Massive Bio SYNERGY-AI site, Littleton

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.